Center for Medicare Advocacy

Advancing Access to Medicare and Healthcare

antipsychotics

HHS Inspector General: Too Many Nursing Home Residents Still Inappropriately Receive Psychotropic Medications

The HHS Office of Inspector General (OIG) reports that, from 2011 through 2019, about 80% of long-stay nursing home residents were prescribed a psychotropic drug (defined as “any drug that affects brain activities associated with mental processes and … [Read more...] about HHS Inspector General: Too Many Nursing Home Residents Still Inappropriately Receive Psychotropic Medications

HHS Inspector General Finds CMS Data Understates Antipsychotic Drug Use in Nursing Homes

A serious and longstanding quality of care problem in nursing homes is the inappropriate use of antipsychotic drugs with residents who have dementia.  A decade ago, the HHS Office of Inspector General (OIG) reported that 83% of claims for … [Read more...] about HHS Inspector General Finds CMS Data Understates Antipsychotic Drug Use in Nursing Homes

Drug Company Sued Over Kickbacks for Off-Label Marketing of Psychotropic Drug for Nursing Home Residents to Pay Over $115 Million

Background When the Centers for Medicare & Medicaid Services (CMS) launched a national campaign to reduce the off-label prescribing of antipsychotic drugs for nursing home residents in 2012, Avanir Pharmaceuticals directed its sales force to … [Read more...] about Drug Company Sued Over Kickbacks for Off-Label Marketing of Psychotropic Drug for Nursing Home Residents to Pay Over $115 Million

Did CMS’s Partnership to Improve Dementia Care Reduce the Inappropriate Prescribing of Antipsychotic Drugs for Nursing Home Residents as Much as CMS Claims? Two Recent Studies Say No

The Centers for Medicare & Medicaid Services (CMS) has ended its campaign to reduce the inappropriate use of antipsychotic drugs for long-stay residents in nursing facilities (formally called the National Partnership to Improve Dementia Care in … [Read more...] about Did CMS’s Partnership to Improve Dementia Care Reduce the Inappropriate Prescribing of Antipsychotic Drugs for Nursing Home Residents as Much as CMS Claims? Two Recent Studies Say No

Elder Justice Alert: New York Times Publishes Article on Drug Use Among Older Adults

Revelations have shed light on an opioid crises in the United States that remained largely hidden until recently. These drugs have affected the lives of children and adults nationwide. Unfortunately, the inappropriate use of medication – … [Read more...] about Elder Justice Alert: New York Times Publishes Article on Drug Use Among Older Adults

Elder Justice Alert: Human Rights Watch Publishes In-Depth Report on Antipsychotic Drug Use in U.S. Nursing Homes

On February 5, 2018, Human Rights Watch published an in-depth report on antipsychotic drug use in U.S. nursing homes. The Report, entitled “‘They Want Docile’: How Nursing Homes in the United States Overmedicate People with … [Read more...] about Elder Justice Alert: Human Rights Watch Publishes In-Depth Report on Antipsychotic Drug Use in U.S. Nursing Homes

CMA Alert, October 18, 2017 – Nursing Home Rights Roundup; ACA Stabilization; More

This Week in ACA Sabotage Bipartisan Agreement on ACA Stabilization Package Nursing Home Rights Roundup CMS Signals End of Campaign to Reduce Unnecessary Use of Antipsychotic Drugs In Nursing Homes; Claim of Success is Grossly … [Read more...] about CMA Alert, October 18, 2017 – Nursing Home Rights Roundup; ACA Stabilization; More

Elder Abuse in Nursing Facilities: The Over-Administration of Antipsychotic Drugs to Nursing Home Residents

The Administration on Aging defines a subcategory of elder abuse – “physical abuse” – as “inflicting physical pain or injury on a senior, e.g. slapping, bruising, or restraining by physical or chemical … [Read more...] about Elder Abuse in Nursing Facilities: The Over-Administration of Antipsychotic Drugs to Nursing Home Residents

Skip to content